HRP20041023A2 - Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity - Google Patents
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity Download PDFInfo
- Publication number
- HRP20041023A2 HRP20041023A2 HR20041023A HRP20041023A HRP20041023A2 HR P20041023 A2 HRP20041023 A2 HR P20041023A2 HR 20041023 A HR20041023 A HR 20041023A HR P20041023 A HRP20041023 A HR P20041023A HR P20041023 A2 HRP20041023 A2 HR P20041023A2
- Authority
- HR
- Croatia
- Prior art keywords
- image
- compound
- mmol
- solution
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37629102P | 2002-04-29 | 2002-04-29 | |
| PCT/US2003/013042 WO2003093266A1 (en) | 2002-04-29 | 2003-04-25 | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20041023A2 true HRP20041023A2 (en) | 2005-02-28 |
Family
ID=29401326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20041023A HRP20041023A2 (en) | 2002-04-29 | 2003-04-25 | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7786305B2 (pl) |
| KR (1) | KR100754760B1 (pl) |
| CN (1) | CN1310917C (pl) |
| AR (1) | AR039489A1 (pl) |
| AU (1) | AU2003234251A1 (pl) |
| BR (1) | BR0309650A (pl) |
| DO (1) | DOP2003000638A (pl) |
| EC (1) | ECSP045392A (pl) |
| HR (1) | HRP20041023A2 (pl) |
| IL (1) | IL164909A (pl) |
| IS (1) | IS7512A (pl) |
| JO (1) | JO2479B1 (pl) |
| MA (1) | MA27119A1 (pl) |
| MX (1) | MXPA04010702A (pl) |
| MY (1) | MY129850A (pl) |
| NO (1) | NO20045235L (pl) |
| PE (1) | PE20040598A1 (pl) |
| PL (1) | PL373401A1 (pl) |
| RU (1) | RU2285004C2 (pl) |
| TW (1) | TWI262077B (pl) |
| UA (1) | UA75828C2 (pl) |
| WO (1) | WO2003093266A1 (pl) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060030582A1 (en) * | 2002-04-29 | 2006-02-09 | Demartino Julie | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| EP1501507B1 (en) * | 2002-04-29 | 2008-05-28 | Merck & Co., Inc. | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| JO2479B1 (en) | 2002-04-29 | 2009-01-20 | ميرك شارب اند دوم ليمتد | Rates for the activity of the chemokine receptor of tetrahydrobranyl cycloneptil tetrahydrobredo predine |
| EP1565436B1 (en) | 2002-11-27 | 2012-04-25 | Incyte Corporation | 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| CN1826334A (zh) * | 2003-03-18 | 2006-08-30 | 麦克公司 | 趋化因子受体活性的四氢吡喃基环戊基杂环酰胺调节剂 |
| WO2004110376A2 (en) * | 2003-06-06 | 2004-12-23 | Merck & Co., Inc. | Ccr-2 antagonists for treatment of neuropathic pain |
| MXPA06004647A (es) | 2003-10-27 | 2006-06-27 | Merck & Co Inc | Sal antagonista de ccr-2. |
| KR20080052683A (ko) | 2003-12-18 | 2008-06-11 | 인사이트 코포레이션 | 케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체 |
| US20070117797A1 (en) * | 2004-01-02 | 2007-05-24 | Goble Stephen D | Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| EP1742919A4 (en) * | 2004-04-26 | 2010-04-28 | Merck Sharp & Dohme | TETRAHYDROPYRANYL-CYCLOPENTYL-1-SUBSTITUTED AND 1,1-DISUBSTITUTED TETRAHYDROISOCHINOLINE MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY |
| EP1755603A4 (en) * | 2004-04-28 | 2009-03-11 | Merck & Co Inc | 3,3-DISUBSTITUTED TETRAHYDROPYRANYL CYCLOPENTYL AMIDE MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY |
| BRPI0510665A (pt) | 2004-05-11 | 2007-12-04 | Incyte Corp | 3-(4-heteroarilcicloexilamino) ciclopentano-carboxiamidas como moduladores de receptores de quimiocinas |
| WO2006004741A2 (en) | 2004-06-28 | 2006-01-12 | Incyte Corporation | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| MXPA06014672A (es) | 2004-06-28 | 2007-03-26 | Incyte Corp | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas. |
| US8067457B2 (en) | 2005-11-01 | 2011-11-29 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of CCR2 |
| WO2007053499A2 (en) | 2005-11-01 | 2007-05-10 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of ccr2 |
| US20080076120A1 (en) * | 2006-09-14 | 2008-03-27 | Millennium Pharmaceuticals, Inc. | Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders |
| US7977358B2 (en) | 2007-07-26 | 2011-07-12 | Hoffmann-La Roche Inc. | Pyrazol derivatives |
| EP2370442B9 (en) | 2008-11-26 | 2013-09-04 | Pfizer Inc. | 3-Aminocyclopentanecarboxamides as chemokine receptor modulators |
| US8728516B2 (en) * | 2009-04-30 | 2014-05-20 | Abbvie Inc. | Stabilized lipid formulation of apoptosis promoter |
| TWI471321B (zh) * | 2009-06-08 | 2015-02-01 | 亞培公司 | Ｂｃｌ－２族群抑制劑之口服醫藥劑型 |
| TWI532484B (zh) * | 2009-06-08 | 2016-05-11 | 艾伯維有限公司 | 包含凋亡促進劑之固態分散劑 |
| US8927009B2 (en) * | 2009-12-22 | 2015-01-06 | Abbvie Inc. | ABT-263 capsule |
| UA113500C2 (xx) | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
| CA3152557A1 (en) | 2010-10-29 | 2012-05-03 | Abbvie Inc. | Solid dispersions containing an apoptosis-inducing agent |
| ES2603129T3 (es) | 2010-11-23 | 2017-02-23 | Abbvie Ireland Unlimited Company | Métodos de tratamiento utilizando inhibidores selectivos de Bcl-2 |
| PT2643322T (pt) | 2010-11-23 | 2017-11-13 | Abbvie Inc | Sais e formas cristalinas de um agente indutor de apoptose |
| AR085435A1 (es) | 2011-03-17 | 2013-10-02 | Bristol Myers Squibb Co | Inhibidores de pirrolopiridazina jak3 y su uso para el tratamiento de enfermedades inflamatorias y autoinmunes |
| WO2012125663A2 (en) * | 2011-03-17 | 2012-09-20 | Merck Sharp & Dohme Corp. | Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists |
| US8822460B2 (en) * | 2012-04-06 | 2014-09-02 | Janssen Pharmaceutica Nv | Fused cyclopentyl antagonists of CCR2 |
| CN105358551A (zh) | 2012-07-19 | 2016-02-24 | 詹森药业有限公司 | Ccr2的八氢环戊并吡咯基拮抗剂 |
| US20140275082A1 (en) | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| DK3297438T3 (da) | 2015-05-21 | 2022-01-17 | Chemocentryx Inc | Ccr2-modulatorer |
| CA3293051A1 (en) | 2017-09-25 | 2026-03-02 | Chemocentryx, Inc. | Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitor |
| CN112105353B (zh) | 2018-01-08 | 2024-04-19 | 凯莫森特里克斯股份有限公司 | Ccr2拮抗剂治疗实体瘤的方法 |
| US20190269664A1 (en) | 2018-01-08 | 2019-09-05 | Chemocentryx, Inc. | Methods of treating solid tumors with ccr2 antagonists |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3647804A (en) * | 1970-02-27 | 1972-03-07 | Upjohn Co | Cycloalkanecarboxamides |
| US3772308A (en) * | 1972-06-02 | 1973-11-13 | Lilly Co Eli | Cyclopentanecetamides and cyclopentaneacetonitriles |
| KR880007441A (ko) * | 1986-12-11 | 1988-08-27 | 알렌 제이.스피겔 | 스피로-치환된 글루타르아미드 이뇨제 |
| RO108347B1 (ro) * | 1989-10-30 | 1994-04-28 | Bellon Labor Sa Roger | DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA |
| CA2143143A1 (en) | 1994-03-08 | 1995-09-09 | Toshihiko Tanaka | 3-phenylpyrrolidine derivatives |
| JPH09291034A (ja) | 1996-02-27 | 1997-11-11 | Yoshitomi Pharmaceut Ind Ltd | 縮合ピリジン化合物およびその医薬としての用途 |
| RU2174123C2 (ru) * | 1996-10-28 | 2001-09-27 | Новартис Аг | Производные 8-арил-1,7-нафтиридина и фармацевтическая композиция, обладающая противовоспалительной активностью |
| GB9812037D0 (en) | 1998-06-04 | 1998-07-29 | Pfizer Ltd | Piperidones |
| US6312689B1 (en) * | 1998-07-23 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Anti-CCR2 antibodies and methods of use therefor |
| WO2000076512A1 (en) | 1999-06-11 | 2000-12-21 | Merck & Co., Inc. | Cyclopentyl modulators of chemokine receptor activity |
| EP1318811B1 (en) * | 2000-08-17 | 2006-08-30 | Merck & Co., Inc. | Cyclopentyl modulators of chemokine receptor activity |
| EP1368354A1 (en) * | 2001-03-07 | 2003-12-10 | Pfizer Products Inc. | Modulators of chemokine receptor activity |
| DE60322877D1 (de) | 2002-04-29 | 2008-09-25 | Merck Sharp & Dohme | Tetrahydropyranylcyclopentyltetrahydroisochino-linmodulatoren der chemokinrezeptoraktivität |
| JO2479B1 (en) | 2002-04-29 | 2009-01-20 | ميرك شارب اند دوم ليمتد | Rates for the activity of the chemokine receptor of tetrahydrobranyl cycloneptil tetrahydrobredo predine |
| EP1501507B1 (en) | 2002-04-29 | 2008-05-28 | Merck & Co., Inc. | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| CA2502174A1 (en) | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| MXPA06004647A (es) | 2003-10-27 | 2006-06-27 | Merck & Co Inc | Sal antagonista de ccr-2. |
| EP1755603A4 (en) | 2004-04-28 | 2009-03-11 | Merck & Co Inc | 3,3-DISUBSTITUTED TETRAHYDROPYRANYL CYCLOPENTYL AMIDE MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY |
-
2003
- 2003-04-22 JO JO200343A patent/JO2479B1/en active
- 2003-04-22 MY MYPI20031503A patent/MY129850A/en unknown
- 2003-04-22 TW TW092109364A patent/TWI262077B/zh not_active IP Right Cessation
- 2003-04-25 MX MXPA04010702A patent/MXPA04010702A/es active IP Right Grant
- 2003-04-25 UA UA20041109704A patent/UA75828C2/uk unknown
- 2003-04-25 PE PE2003000418A patent/PE20040598A1/es not_active Application Discontinuation
- 2003-04-25 PL PL03373401A patent/PL373401A1/pl not_active Application Discontinuation
- 2003-04-25 RU RU2004134604/04A patent/RU2285004C2/ru not_active IP Right Cessation
- 2003-04-25 AU AU2003234251A patent/AU2003234251A1/en not_active Abandoned
- 2003-04-25 HR HR20041023A patent/HRP20041023A2/hr not_active Application Discontinuation
- 2003-04-25 WO PCT/US2003/013042 patent/WO2003093266A1/en not_active Ceased
- 2003-04-25 KR KR1020047017373A patent/KR100754760B1/ko not_active Expired - Fee Related
- 2003-04-25 CN CNB038150417A patent/CN1310917C/zh not_active Expired - Fee Related
- 2003-04-25 BR BR0309650-5A patent/BR0309650A/pt not_active Application Discontinuation
- 2003-04-29 DO DO2003000638A patent/DOP2003000638A/es unknown
- 2003-04-29 AR ARP030101487A patent/AR039489A1/es unknown
-
2004
- 2004-05-28 US US10/856,012 patent/US7786305B2/en active Active
- 2004-10-18 IS IS7512A patent/IS7512A/is unknown
- 2004-10-27 EC EC2004005392A patent/ECSP045392A/es unknown
- 2004-10-28 IL IL164909A patent/IL164909A/en not_active IP Right Cessation
- 2004-11-17 MA MA27955A patent/MA27119A1/fr unknown
- 2004-11-29 NO NO20045235A patent/NO20045235L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200307543A (en) | 2003-12-16 |
| PE20040598A1 (es) | 2004-10-05 |
| MY129850A (en) | 2007-05-31 |
| US20050101628A1 (en) | 2005-05-12 |
| JO2479B1 (en) | 2009-01-20 |
| TWI262077B (en) | 2006-09-21 |
| DOP2003000638A (es) | 2003-11-30 |
| KR100754760B1 (ko) | 2007-09-04 |
| US7786305B2 (en) | 2010-08-31 |
| RU2285004C2 (ru) | 2006-10-10 |
| CN1662532A (zh) | 2005-08-31 |
| IL164909A (en) | 2010-04-15 |
| AU2003234251A1 (en) | 2003-11-17 |
| NO20045235L (no) | 2004-11-29 |
| AU2003234251A8 (en) | 2003-11-17 |
| IL164909A0 (en) | 2005-12-18 |
| HK1081967A1 (en) | 2006-05-26 |
| KR20050000413A (ko) | 2005-01-03 |
| IS7512A (is) | 2004-10-18 |
| PL373401A1 (pl) | 2005-08-22 |
| AR039489A1 (es) | 2005-02-23 |
| BR0309650A (pt) | 2005-04-26 |
| MXPA04010702A (es) | 2005-02-17 |
| ECSP045392A (es) | 2005-01-03 |
| RU2004134604A (ru) | 2005-05-27 |
| MA27119A1 (fr) | 2004-12-20 |
| CN1310917C (zh) | 2007-04-18 |
| WO2003093266A1 (en) | 2003-11-13 |
| UA75828C2 (en) | 2006-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20041023A2 (en) | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity | |
| US20100234409A1 (en) | Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity | |
| US7566726B2 (en) | 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity | |
| US7700772B2 (en) | Amino heterocyclic modulators of chemokine receptor activity | |
| US7410961B2 (en) | 2,6-disubstituted piperiddines as modulators | |
| US20070117797A1 (en) | Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity | |
| US7557124B2 (en) | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity | |
| US20060183731A1 (en) | 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity | |
| US20070299104A1 (en) | Tetrahydropyranyl Cyclopentyl 1-Substituted and 1,1-Disubstituted Tetrahydroisoquinoline Modulators of Chemokine Receptor Activity | |
| JP2007501795A (ja) | ケモカイン受容体活性のテトラヒドロピランヘテロ環シクロペンチルヘテロアリールモジュレーター |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| PNAN | Change of the applicant name, address/residence |
Owner name: MERCK SHARP & DOHME CORP., US |
|
| OBST | Application withdrawn | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20110408 Year of fee payment: 9 |